Phillips-Medisize’s increased business to benefit Molex plant in Arkansas

Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader

Phillips-Medisize, Dance Biopharm ink deal for inhaled insulin device

Privately-held biotech Dance Biopharm and Phillips-Medisize have entered into a joint development deal for a connected drug-delivery device for inhaled insulin. The agreement gives Phillips-Medisize, which already designs and manufactures devices for Dance, the development work for future enhancements of Dance’s devices, as well as commercial manufacturing of the inhaled insulin delivery device when it gets to the market.

Phillips-Medisize showing off respiratory device capabilities at DDL2017

Phillips-Medisize will be exhibiting at the Drug Delivery to the Lungs Conference in Scotland next month, providing a chance to further tout its respiratory device capabilities. The Hudson, Wis.–based contract manufacturer boasts more than 30 years at the forefront of inhalation technology. The company’s experience ranges from feasibility to selecting the right components – all the way through

Phillips-Medisize sells Medisize BV business in Europe

Phillips-Medisize has sold its Medisize BV business to U.K.-based Flexicare, the companies announced today. Financial terms of the deal were not disclosed. Medisize BV is a manufacturer specializing in a wide array of respiratory and anesthesia products for critical care, neonatology, emergency, homecare and radiology. It has operations in the Netherlands, and subsidiaries in Germany

How Phillips-Medisize supported a Medical Design Excellence Awards finalist

Phillips-Medisize congratulates ivWatch on their recent recognition as a finalist in Medical Design Excellence Awards (MDEA). ivWatch LLC is a nominee for the Model 400 device in the nonsurgical hospital supplies and equipment category. Winners will be announced on June 13  in New York during a ceremony at MD&M East. The ivWatch Model 400 is

Phillips-Medisize builds new 80,000 square ft facility in Menomonie, Wis.

Phillips-Medisize announced plans to open a new 80,000 square ft manufacturing facility on its Menomonie, Wis. campus. The state-of-the-art facility manufactures high volume prefilled drug delivery systems and is planned to be complete in 2017. Investment in the new facility is driven by the signing of a new supply contract with a major biopharmaceutical company and is

Showcasing connected health capabilities at PDA Universe of Pre-Filled Syringes and Injection Devices conference

Phillips-Medisize, along with Medicom Innovation Partner, will showcase their capabilities at next week’s PDA Universe of Pre-filled Syringes and Injection Devices conference in Huntington Beach, CA. This conference brings together industry and regulatory experts to share their experiences with the benefits, convenience and innovations pre-filled syringes and injection devices. With this year’s conference key focus

Phillips-Medisize acquires Injectronics

Phillips-Medisize announced that it has completed its previously announced acquisition of Injectronics. The terms of the transaction were not disclosed. This acquisition expands Phillips-Medisize’s footprint, providing purpose-built facilities in the Northeastern United States, a global center of biopharmaceutical and medical device innovation and opportunities for continued growth in these areas. Phillips-Medisize

Phillips-Medisize to acquire Injectronics

Phillips-Medisize announced that it has agreed to acquire Injectronics. Injectronics provides contract engineering and manufacturing services to consumable diagnostics and medical device customers. Terms of the transaction were not disclosed. Through this acquisition, Phillips-Medisize will add two manufacturing locations in the Northeastern United States, a global center of biopharmaceutical and medical device innovation. The current

Phillips-Medisize appoints new general manager

Phillips-Medisize Corporation announced today the appointment of Richard Even as General Manager of BioPharma and the medical campus in Menomonie, Wisconsin. This is the latest in a series of strategic hires driven by the company’s continued growth in biopharma drug delivery devices, consumable diagnostics, and medical devices. Mr. Even comes to Phillips-Medisize most recently from

Phillips-Medisize completes 17,000 sq. ft. dedicated clinical and pilot facility

Phillips-Medisize Corp. recently added a 17,000 square foot clinical and pilot facility, dedicated to medical device and drug delivery device, in Menomonie, Wisconsin. This dedicated facility is a direct result of the company’s continued commitment to purpose-built facilities and the support of several customers. The expansion provides a dedicated, cGMP clinical and pilot-scale facility for

Phillips-Medisize receives IMDA award

Phillips-Medisize was the recipient of this year’s In-Mold Decorating Associations, Best In-Mold Decorated Part Gold award. Through the partnership with ZoMazz, the in-mold decorating (IMD) applique supplier, the team was able to overcome various challenges with the very intricate designs. The successful IMD capabilities enabled the customer to launch 20 different designs for their health

Phillips-Medisize recognized in Medical Design Excellence Awards

Phillips-Medisize announced it has won the Gold Award in the Diagnostic Products and Systems category at the 18th Annual Medical Design Excellence Awards (MDEA) ceremony in New York City. The company was cited for its role as an outsourced design and manufacturing partner of Exact Sciences, Inc. of Madison, Wis. The product, Cologuard, is the